XB3

Welcome to the Brand page for “XB3”, which is offered here for Pharmaceutical products, synthetic peptides and synthetic peptide fragments that promote the delivery of therapeutic agents to the brain, for use in the treatment of neurological disorders, pain, autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancers, and infectious diseases;drug discovery services, research, development, engineering and testing of pharmaceuticals and substances, peptides and peptide fragments that promote the delivery of therapeutic agents to the brain, for use in the treatment of neurological disorders, pain, autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancers, and infectious diseases;.

Its status is currently believed to be active. Its class is unavailable. “XB3” is believed to be currently owned by “Bioasis Technologies, Inc.”